Literature DB >> 24784832

A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes.

Matthew D Campbell1, Mark Walker2, Michael I Trenell2, Emma J Stevenson1, Daniel Turner3, Richard M Bracken3, James A Shaw2, Daniel J West4.   

Abstract

OBJECTIVE: To examine the influence of the glycemic index (GI) of foods consumed after evening exercise on postprandial glycemia, metabolic and inflammatory markers, and nocturnal glycemic control in type 1 diabetes. RESEARCH DESIGN AND METHODS: On two evenings (∼1700 h), 10 male patients (27 ± 5 years of age, HbA1c 6.7 ± 0.7% [49.9 ± 8.1 mmol/mol]) were administered a 25% rapid-acting insulin dose with a carbohydrate bolus 60 min before 45 min of treadmill running. At 60 min postexercise, patients were administered a 50% rapid-acting insulin dose with one of two isoenergetic meals (1.0 g carbohdyrate/kg body mass [BM]) matched for macronutrient content but of either low GI (LGI) or high GI (HGI). At 180 min postmeal, the LGI group ingested an LGI snack and the HGI group an HGI snack (0.4 g carbohdyrate/kg BM) before returning home (∼2300 h). Interval samples were analyzed for blood glucose and lactate; plasma glucagon, epinephrine, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α); and serum insulin, cortisol, nonesterified fatty acid, and β-hydroxybutyrate concentrations. Interstitial glucose was recorded for 20 h postlaboratory attendance through continuous glucose monitoring.
RESULTS: Following the postexercise meal, an HGI snack induced hyperglycemia in all patients (mean ± SD glucose 13.5 ± 3.3 mmol/L) and marked increases in TNF-α and IL-6, whereas relative euglycemia was maintained with an LGI snack (7.7 ± 2.5 mmol/L, P < 0.001) without inflammatory cytokine elevation. Both meal types protected all patients from early hypoglycemia. Overnight glycemia was comparable, with a similar incidence of nocturnal hypoglycemia (n = 5 for both HGI and LGI).
CONCLUSIONS: Consuming LGI food with a reduced rapid-acting insulin dose following evening exercise prevents postprandial hyperglycemia and inflammation and provides hypoglycemia protection for ∼8 h postexercise; however, the risk of late nocturnal hypoglycemia remains.
© 2014 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24784832     DOI: 10.2337/dc14-0186

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

Review 1.  Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles.

Authors:  Michael C Riddell; Dessi P Zaharieva; Loren Yavelberg; Ali Cinar; Veronica K Jamnik
Journal:  J Diabetes Sci Technol       Date:  2015-10-01

2.  Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Authors:  Darrell M Wilson; Peter M Calhoun; David M Maahs; H Peter Chase; Laurel Messer; Bruce A Buckingham; Tandy Aye; Paula K Clinton; Irene Hramiak; Craig Kollman; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2015-03-11       Impact factor: 6.118

3.  Predicting Nocturnal Hypoglycemia from Continuous Glucose Monitoring Data with Extended Prediction Horizon.

Authors:  Long Vu; Sarah Kefayati; Tsuyoshi Idé; Venkata Pavuluri; Gretchen Jackson; Lisa Latts; Yuxiang Zhong; Pratik Agrawal; Yuan-Chi Chang
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

4.  Assessment of the "Second Day" Exercise Effect on Glycemic Control, Insulin Requirements, and CHO Intake in Type 1 Diabetes Adults.

Authors:  Michael Müller-Korbsch; Lisa Frühwald; Michael Heer; Maria Fangmeyer-Binder; David Reinhart-Mikocki; Peter Fasching
Journal:  J Diabetes Sci Technol       Date:  2019-10-04

5.  The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study.

Authors:  Daniel J West; Matthew D Campbell; Javier T Gonzalez; Mark Walker; Emma J Stevenson; Fahad W Ahmed; Stephanie Wijaya; James A Shaw; Jolanta U Weaver
Journal:  Cardiovasc Diabetol       Date:  2015-06-05       Impact factor: 9.951

6.  Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial.

Authors:  Matthew D Campbell; Mark Walker; Richard M Bracken; Daniel Turner; Emma J Stevenson; Javier T Gonzalez; James A Shaw; Daniel J West
Journal:  BMJ Open Diabetes Res Care       Date:  2015-05-12

7.  Prevention of exercise-associated dysglycemia: a case study-based approach.

Authors:  Dessi P Zaharieva; Michael C Riddell
Journal:  Diabetes Spectr       Date:  2015-01

8.  Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial.

Authors:  Ryo Iga; Hiroshi Uchino; Ken Kanazawa; Shuki Usui; Masahiko Miyagi; Naoki Kumashiro; Hiroshi Yoshino; Yasuyo Ando; Takahisa Hirose
Journal:  Diabetes Ther       Date:  2017-05-25       Impact factor: 2.945

Review 9.  Low Glycemic Index Prototype Isomaltulose-Update of Clinical Trials.

Authors:  Constanze Christin Maresch; Sebastian Friedrich Petry; Stephan Theis; Anja Bosy-Westphal; Thomas Linn
Journal:  Nutrients       Date:  2017-04-13       Impact factor: 5.717

10.  Effect of insulin therapy and dietary adjustments on safety and performance during simulated soccer tests in people with type 1 diabetes: study protocol for a randomized controlled trial.

Authors:  Javier Calvo-Marín; Gabriel Torrealba-Acosta; Matthew Campbell; Jesse Gaboury; Ajmol Ali; Chih Hao Chen-Ku
Journal:  Trials       Date:  2017-07-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.